1. Home
  2. IPHA vs IH Comparison

IPHA vs IH Comparison

Compare IPHA & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • IH
  • Stock Information
  • Founded
  • IPHA 1999
  • IH 1996
  • Country
  • IPHA France
  • IH China
  • Employees
  • IPHA N/A
  • IH N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • IH Other Consumer Services
  • Sector
  • IPHA Health Care
  • IH Real Estate
  • Exchange
  • IPHA Nasdaq
  • IH Nasdaq
  • Market Cap
  • IPHA 160.1M
  • IH 146.3M
  • IPO Year
  • IPHA 2019
  • IH 2020
  • Fundamental
  • Price
  • IPHA $1.95
  • IH $2.98
  • Analyst Decision
  • IPHA Hold
  • IH
  • Analyst Count
  • IPHA 2
  • IH 0
  • Target Price
  • IPHA $2.00
  • IH N/A
  • AVG Volume (30 Days)
  • IPHA 21.4K
  • IH 17.4K
  • Earning Date
  • IPHA 09-17-2025
  • IH 09-18-2025
  • Dividend Yield
  • IPHA N/A
  • IH 2.83%
  • EPS Growth
  • IPHA N/A
  • IH N/A
  • EPS
  • IPHA N/A
  • IH 0.29
  • Revenue
  • IPHA $14,839,695.00
  • IH $123,215,612.00
  • Revenue This Year
  • IPHA $350.96
  • IH $39.02
  • Revenue Next Year
  • IPHA $32.92
  • IH N/A
  • P/E Ratio
  • IPHA N/A
  • IH $10.34
  • Revenue Growth
  • IPHA N/A
  • IH N/A
  • 52 Week Low
  • IPHA $1.29
  • IH $1.47
  • 52 Week High
  • IPHA $3.51
  • IH $3.60
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 50.85
  • IH 56.90
  • Support Level
  • IPHA $1.95
  • IH $2.89
  • Resistance Level
  • IPHA $2.10
  • IH $2.98
  • Average True Range (ATR)
  • IPHA 0.07
  • IH 0.12
  • MACD
  • IPHA 0.02
  • IH 0.01
  • Stochastic Oscillator
  • IPHA 66.09
  • IH 71.05

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

Share on Social Networks: